ISO 13485 · Medical devices, quality management systems

ISO 13485 8.3.1

General

ISO 13485 8.3.1 is the clause titled “General” in ISO 13485, the medical device quality management standard. Since 2021, 1 FDA warning letter has cited it.

Letters citing it
1 since 2021
Jan 1 to Oct 30, 2026
1 against 0 on the same dates in 2025
Most often cited with
21 CFR 801.20, in 1 letter
Closed out
0% of these letters have a published close-out
See the letter citing ISO 13485 8.3.1 →

Letters citing it, by year issued

It is a medical device letter. 2026 runs to Oct 30, 2026. Pick a year to see its letters.

  1. 02021
  2. 02022
  3. 02023
  4. 02024
  5. 02025
  6. 12026

What FDA writes when it cites it

The finding headings that cite ISO 13485 8.3.1 most often, as written in the letters.

  • 1 letterFailure to ensure that product which does not conform to product requirements is identified and controlled to prevent its unintended use or delivery; and failure to document a procedure defining the controls and related…

The standard

This is a clause reference cited in an FDA letter. Full ISO 13485:2016 text is not reproduced here. Read the standard for the complete requirements.

ISO 13485:2016 on iso.org (opens in a new tab)

Cited alongside it

Regulations that appear in the same letters as ISO 13485 8.3.1.

Latest letters citing it

The letter citing ISO 13485 8.3.1 that FDA posted most recently.

See the letter citing ISO 13485 8.3.1 →
For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

Counts include every citation in a letter, as the Letters filter does. How this database is built.

Every letter by dateHow this database is built

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.